中科信息(300678.SZ):在自動推理和定理機器證明、高速機器視覺、人工智能機器學習、圖像視覺與智能分析領域處於同內領先、國際先進水平
格隆匯7月5日丨有投資者向中科信息(300678.SZ)提問,“請問你們的技術和研究成果是否在一些方面超越美歐等國家。”
中科信息回覆稱,公司擁有中國科學院張景中院士、楊路科學家領銜的國內一流科研團隊,在自動推理和定理機器證明、高速機器視覺、人工智能機器學習、圖像視覺與智能分析領域處於同內領先、國際先進水平。關於公司產品與業務介紹,請關注公司披露的定期報吿等公吿。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.